The Patient Access Marketplace
Let SubjectWell connect your trial or treatment to tens of millions of motivated patients with known conditions.
Find Patients
We already have the patients you need.
Tens of millions of patients, motivated by clinical research as a new care option, have already joined the SubjectWell marketplace with over 300,000 newly registering each month. These patients are unique: often new to clinical trials and always with known medical conditions. SubjectWell’s unmatched patient access covers more than 175 therapeutic areas, spanning 6 continents and with 47% of those registered self-reporting as people of color.
3,000+ patients screened every day
300,000+ patients registering monthly
47% people of color in the marketplace
Over 175 therapeutic areas
Enrolling patients on 6 continents
Known Conditions + Machine Learning = Quality
Patients registering into the SubjectWell marketplace share their contact information and complete a short heath profile including conditions they’re interested in treating. Using advanced machine learning techniques with dozens of parameters, we’ll present your trial or treatment to the patients most likely to be interested. This results in higher-quality referrals and leads: real patients, with real motivation, taking real action to improve their options for care.
How it works
SubjectWell’s general awareness advertising finds a person interested in new treatment options.
The patient confirms their interest and conditions with SubjectWell.
Machine learning algorithms present trial and treatment options matching their conditions.
Patients choose the trial or treatment that is right for them.
A history of success with sponsor and CRO partners.
Since launching, SubjectWell has built the largest, most trusted, direct patient access marketplace. We’ve helped tens of thousands of patients randomize by working with over 4,700 sites across more than 700 studies. Currently, 18 of the top 20 pharmaceutical companies have used SubjectWell’s patient access to enroll their studies. Today, we offer a breadth of solutions both in support of enrolling patients in clinical research as well as building public awareness of market-ready treatments.
10,000+ randomized patients
700+ studies
350,000+ referrals
4,700+ sites
